CD47 and melanoma: Previous studies by our group and others identified integrin-associated protein CD47 as the critical myeloid lineage checkpoint that is overexpressed by various types of tumor cells, including melanoma, and inhibits innate immunity-mediated anti-tumor responses (1–4).